The Riverside Company Invests in Altius Group Holdings

Riverside-Backed Altius Acquires Nabenet

October 20, 2021

Healthcare Services

The Riverside Company has invested in Nabenet as an add-on to its Australian allied-health platform, Altius Group Holdings; terms were not disclosed. Nabenet, based in Hawthorn, Victoria, operates 17 locations across Victoria and provides occupational rehabilitation services and nurse supply to regional hospitals and prisons, expanding Altius' presence and capabilities in workplace health and rehabilitation.

The Riverside Company Invests in Alpha-H

April 30, 2019

Consumer Products

The Riverside Company has invested in Alpha-H, the Australian skincare maker best known for its Liquid Gold exfoliating treatment, to support the brand's international growth and product development. Riverside will partner with Alpha-H's existing management and shareholders to accelerate distribution across new and existing regions; KPMG M&A advised Alpha-H and Riverside was advised by KPMG, Deloitte and Herbert Smith Freehills.

The Riverside Company Invests in Independent Living Specialists (ILS)

April 6, 2020

Healthcare Services

The Riverside Company has made a growth investment in Independent Living Specialists (ILS), a Sydney-based retailer and distributor of mobility and homecare products. Riverside said the capital will support ILS's national expansion—both organically and via bolt-on acquisitions—and accelerate growth of its retail showrooms, clinically trained field force and online channels.

The Riverside Company Invests in Virtual IT Group

June 21, 2024

IT Services

The Riverside Company has signed a definitive agreement to make an investment in Australian managed service provider Virtual IT Group (VITG). The growth capital will support VITG's platform expansion, organic growth and M&A activity while founder Christian Pacheco remains Managing Director and a significant shareholder.

The Riverside Company Invests in Avance Clinical

November 9, 2021

Healthcare Services

The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.

The Riverside Company Invests in EventsAIR

April 1, 2022

Cloud & SaaS

The Riverside Company has made a growth investment in EventsAIR, an Australian provider of cloud-based event management software, in partnership with founder Trevor Gardiner and members of management. Riverside will support EventsAIR's international expansion into North America and Europe and invest in product evolution and M&A to accelerate global growth.